Related Experiment Video

Updated: Sep 18, 2026

An Experimental Paradigm for the Prediction of Post-Operative Pain (PPOP)
14:56

An Experimental Paradigm for the Prediction of Post-Operative Pain (PPOP)

Published on: January 27, 2010

[Analysis of prophylactic antibiotics for cesarean section]

Chunmei Li1, Weiyue Zeng, Yi Chen

  • 1Department of Obstetrics and Gynecology, The Second Huaxi Hospital of Sichuan University, Chengdu 610041, China.

Zhonghua Fu Chan Ke Za Zhi
|April 16, 2002
PubMed

Insights

Penicillin and Ampicillin remain common choices for cesarean section prophylaxis. Mezlocillin also shows promise, offering reduced puerperal morbidity and fewer side effects in surgical prophylaxis.

Area of Science:

  • Obstetrics and Gynecology
  • Infectious Diseases
  • Pharmacology

Context:

  • Cesarean section is a common surgical procedure worldwide.
  • Antibiotic prophylaxis is crucial for preventing surgical site infections.
  • Evaluating antibiotic efficacy and safety is essential for optimal patient outcomes.

Purpose:

  • To determine the most effective antibiotic regimen for cesarean section prophylaxis.
  • To compare the incidence of postoperative fever and puerperal morbidity among different antibiotic groups.
  • To assess the side effect profiles of various prophylactic antibiotics used in cesarean sections.

Summary:

  • A retrospective study analyzed 1,266 cesarean sections comparing six prophylactic antibiotic regimens: Penicillin/Ampicillin, Mezlocillin sodium, Sulbactam/Ampicillin, Ciprofloxacin, Clindamycin, and Cefacidal.
  • Mezlocillin demonstrated lower rates of puerperal morbidity and fewer side effects compared to other regimens.
  • While Penicillin and Ampicillin are frequently used, Mezlocillin presents a favorable alternative for cesarean section prophylaxis.

Impact:

  • Findings can guide clinical practice in selecting appropriate prophylactic antibiotics for cesarean sections.
  • Reduced puerperal morbidity and side effects can lead to improved patient recovery and decreased healthcare costs.
  • This study contributes to evidence-based guidelines for antibiotic use in obstetric surgery.
Abstract

More Related Videos

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

Related Concept Videos

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...